In January 2017, Randox voluntarily reported evidence of data manipulation in the analysis of drug driving samples. The company stated that they would be unable to “stand-over” the results of about 10,500 cases. In 2018, the company reported that 4,200 samples were still to be re-tested and that all work was to be completed by…